QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. QLT’s research and development efforts are focused on pharmaceutical products in the fields of ophthalmology. QLT was founded in 1981 by a group of University of British Columbia professors, including Dr. Julia Levy who served as the Company's President and CEO from 1995 to 2002. QLT went public in 1986. In November of 2004, QLT merged with Atrix.

Acquired Companies: Atrix Laboratories Inc.